Christopher Marriott

2.9k total citations
80 papers, 2.4k citations indexed

About

Christopher Marriott is a scholar working on Pulmonary and Respiratory Medicine, Food Science and Molecular Biology. According to data from OpenAlex, Christopher Marriott has authored 80 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Pulmonary and Respiratory Medicine, 21 papers in Food Science and 17 papers in Molecular Biology. Recurrent topics in Christopher Marriott's work include Inhalation and Respiratory Drug Delivery (34 papers), Microencapsulation and Drying Processes (17 papers) and Drug Solubulity and Delivery Systems (10 papers). Christopher Marriott is often cited by papers focused on Inhalation and Respiratory Drug Delivery (34 papers), Microencapsulation and Drying Processes (17 papers) and Drug Solubulity and Delivery Systems (10 papers). Christopher Marriott collaborates with scholars based in United Kingdom, United States and Italy. Christopher Marriott's co-authors include Gary P. Martin, Xian Ming Zeng, J.N. Pritchard, Xian‐Ming Zeng, Hassan Larhrib, S.K. Tee, David Prime, Darragh Murnane, I.W. Kellaway and Roger S. Crowther and has published in prestigious journals such as Analytical Biochemistry, FEBS Letters and International Journal of Pharmaceutics.

In The Last Decade

Christopher Marriott

78 papers receiving 2.3k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Christopher Marriott 1.5k 830 772 340 271 80 2.4k
Hartwig Steckel 1.4k 0.9× 880 1.1× 771 1.0× 320 0.9× 244 0.9× 73 2.5k
John N. Staniforth 1.1k 0.7× 889 1.1× 635 0.8× 350 1.0× 159 0.6× 94 2.3k
David Lechuga‐Ballesteros 1.1k 0.7× 819 1.0× 837 1.1× 254 0.7× 404 1.5× 59 2.5k
Philip Chi Lip Kwok 1.3k 0.8× 666 0.8× 533 0.7× 450 1.3× 415 1.5× 87 2.7k
Peter R. Byron 2.9k 1.9× 945 1.1× 549 0.7× 508 1.5× 415 1.5× 99 3.9k
Hirokazu Okamoto 1.0k 0.7× 1.2k 1.4× 590 0.8× 159 0.5× 565 2.1× 112 2.4k
Heidi M. Mansour 2.1k 1.4× 1.0k 1.2× 601 0.8× 282 0.8× 569 2.1× 123 3.7k
Xian Ming Zeng 1.1k 0.7× 502 0.6× 568 0.7× 288 0.8× 82 0.3× 21 1.4k
Kazumi Danjo 858 0.6× 2.0k 2.4× 739 1.0× 189 0.6× 541 2.0× 129 3.3k
Francesca Buttini 1.5k 0.9× 1.2k 1.4× 471 0.6× 147 0.4× 384 1.4× 97 2.7k

Countries citing papers authored by Christopher Marriott

Since Specialization
Citations

This map shows the geographic impact of Christopher Marriott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Marriott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Marriott more than expected).

Fields of papers citing papers by Christopher Marriott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Marriott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Marriott. The network helps show where Christopher Marriott may publish in the future.

Co-authorship network of co-authors of Christopher Marriott

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Marriott. A scholar is included among the top collaborators of Christopher Marriott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Marriott. Christopher Marriott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marriott, Christopher, et al.. (2011). The ‘stage-by-stage’ deposition of drugs from commercial single-active and combination dry powder inhaler formulations. European Journal of Pharmaceutical Sciences. 43(4). 225–235. 14 indexed citations
2.
Marriott, Christopher, et al.. (2009). Aerodynamic deposition of combination dry powder inhaler formulations in vitro: A comparison of three impactors. International Journal of Pharmaceutics. 388(1-2). 40–51. 55 indexed citations
3.
Murnane, Darragh, Christopher Marriott, & Gary P. Martin. (2008). Polymorphic control of inhalation microparticles prepared by crystallization. International Journal of Pharmaceutics. 361(1-2). 141–149. 13 indexed citations
4.
Murnane, Darragh, Gary P. Martin, & Christopher Marriott. (2008). Investigations into the Formulation of Metered Dose Inhalers of Salmeterol Xinafoate and Fluticasone Propionate Microcrystals. Pharmaceutical Research. 25(10). 2283–2291. 7 indexed citations
5.
Murnane, Darragh, Gary P. Martin, & Christopher Marriott. (2008). Dry Powder Formulations for Inhalation of Fluticasone Propionate and Salmeterol Xinafoate Microcrystals. Journal of Pharmaceutical Sciences. 98(2). 503–515. 22 indexed citations
6.
Murnane, Darragh, Christopher Marriott, & Gary P. Martin. (2007). Developing an environmentally benign process for the production of microparticles: Amphiphilic crystallization. European Journal of Pharmaceutics and Biopharmaceutics. 69(1). 72–82. 17 indexed citations
7.
Marriott, Christopher, et al.. (2006). Development of a laser diffraction method for the determination of the particle size of aerosolised powder formulations. International Journal of Pharmaceutics. 326(1-2). 39–49. 24 indexed citations
8.
Zeng, Xian‐Ming, et al.. (2006). Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers. International Journal of Pharmaceutics. 333(1-2). 45–55. 27 indexed citations
9.
Martin, Gary P., et al.. (2006). Characterisation of a Carrier-Free Dry Powder Aerosol Formulation Using Inertial Impaction and Laser Diffraction. Pharmaceutical Research. 23(9). 2210–2219. 13 indexed citations
10.
Srichana, Teerapol, et al.. (2005). The correlation of urinary levels of albuterol and its metabolites isomers following inhalation from a dry powder inhaler and in vitro particle size characterisation. Pulmonary Pharmacology & Therapeutics. 20(1). 36–45. 8 indexed citations
11.
Larhrib, Hassan, Gary P. Martin, David Prime, & Christopher Marriott. (2003). Characterisation and deposition studies of engineered lactose crystals with potential for use as a carrier for aerosolised salbutamol sulfate from dry powder inhalers. European Journal of Pharmaceutical Sciences. 19(4). 211–221. 68 indexed citations
12.
Tee, S.K., Gary P. Martin, Anthony Leeds, et al.. (2001). The influence of a tertiary component on the in vivo disposition of salbutamol isomers aerosolised from a dry powder inhaler formulation. Thorax. 56. 61–62. 5 indexed citations
13.
Zeng, Xian‐Ming, Gary P. Martin, Christopher Marriott, & J.N. Pritchard. (2001). Lactose as a carrier in dry powder formulations: The influence of surface characteristics on drug delivery. Journal of Pharmaceutical Sciences. 90(9). 1424–1434. 128 indexed citations
14.
Zeng, Xian Ming, Gary P. Martin, Christopher Marriott, & J.N. Pritchard. (2000). Crystallization of Lactose from Carbopol Gels. Pharmaceutical Research. 17(7). 879–886. 29 indexed citations
15.
Dodoo, Alexander, Sukhvinder S. Bansal, David J. Barlow, et al.. (2000). Use of Alveolar Cell Monolayers of Varying Electrical Resistance to Measure Pulmonary Peptide Transport. Journal of Pharmaceutical Sciences. 89(2). 223–231. 14 indexed citations
16.
Zeng, Xian Ming, et al.. (1999). Effects of particle size and adding sequence of fine lactose on the deposition of salbutamol sulphate from a dry powder formulation. International Journal of Pharmaceutics. 182(2). 133–144. 116 indexed citations
17.
Barlow, David J., et al.. (1999). Synthesis and Properties of (6,7-Dimethoxy-4-coumaryl)alanine: A Fluorescent Peptide Label. Analytical Biochemistry. 270(1). 15–23. 15 indexed citations
18.
Marriott, Christopher, et al.. (1994). Tamoxifen decreases drug efflux from liposomes: Relevance to its ability to reverse multidrug resistance in cancer cells?. FEBS Letters. 344(2-3). 221–224. 31 indexed citations
19.
Lethem, Michael I., Stuart L. James, & Christopher Marriott. (1990). The Role of Mucous Glycoproteins in the Rheologic Properties of Cystic Fibrosis Sputum. American Review of Respiratory Disease. 142(5). 1053–1058. 58 indexed citations
20.
Hanlon, Geoffrey W., et al.. (1989). The migration of bacteria through gels in the presence of IUCD monofilament tails. Contraception. 39(2). 205–216. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hartwig Steckel Breakdown of academic impact, for papers by John N. Staniforth Breakdown of academic impact, for papers by David Lechuga‐Ballesteros Breakdown of academic impact, for papers by Philip Chi Lip Kwok Breakdown of academic impact, for papers by Peter R. Byron Breakdown of academic impact, for papers by Hirokazu Okamoto Breakdown of academic impact, for papers by Heidi M. Mansour Breakdown of academic impact, for papers by Xian Ming Zeng Breakdown of academic impact, for papers by Kazumi Danjo Breakdown of academic impact, for papers by Francesca Buttini
Rankless by CCL
2026